Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Experts Concerned About Increased Chinese-Drug Exports To U.S., Europe (China)

This article was originally published in PharmAsia News

Executive Summary

Pharmaceutical companies in China have doubled their exports to the United States in the past five years, and some industry experts are raising national-security concerns. They note that the ingredients for anthrax vaccines no longer exist in the West, leaving the area to rely on China and India to produce the drugs after Western supplies are exhausted. There also are concerns about the safety of Chinese factories and the long-term stability of trade between China, and U.S. European industry experts voice similar national-security concerns. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065665

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel